Literature DB >> 23795730

Cellular responses to hypoxia in the pulmonary circulation.

David J Welsh1, Andrew J Peacock.   

Abstract

Hypoxia can be defined as a reduction in available oxygen, whether in a whole organism or in a tissue or cell. It is a real life cause of pulmonary hypertension in humans both in terms of patients with chronic hypoxic lung disease and people living at high altitude. The effect of hypoxia on the pulmonary vasculature can be described in two ways; Hypoxic pulmonary vasoconstriction (HPV) (resulting from smooth muscle cell contraction) and pulmonary vascular remodelling (PVR) (resulting from pulmonary vascular cell proliferation). The pulmonary artery is made up of three resident cell types, the endothelial (intima), smooth muscle (media) and fibroblast (adventitia) cells. This review will examine the effects of hypoxia on the cells of the pulmonary vasculature and give an insight into the possible underlying mechanisms.

Entities:  

Mesh:

Year:  2013        PMID: 23795730     DOI: 10.1089/ham.2013.1016

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  16 in total

1.  Sleep-Disordered Breathing in Adults with Precapillary Pulmonary Hypertension: Prevalence and Predictors of Nocturnal Hypoxemia.

Authors:  Marcia S Murta; Ricardo L M Duarte; Daniel Waetge; David Gozal; Alexandre P Cardoso; Fernanda C Q Mello
Journal:  Lung       Date:  2022-06-18       Impact factor: 3.777

2.  Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension.

Authors:  Yan Xing; Xiaodong Zheng; Yao Fu; Jing Qi; Minghui Li; Mingfei Ma; Shuang Wang; Shuzhen Li; Daling Zhu
Journal:  Mol Ther       Date:  2019-08-22       Impact factor: 11.454

Review 3.  The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.

Authors:  Steven C Pugliese; Jens M Poth; Mehdi A Fini; Andrea Olschewski; Karim C El Kasmi; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-21       Impact factor: 5.464

4.  Adventitial alterations are the main features in pulmonary artery remodeling due to long-term chronic intermittent hypobaric hypoxia in rats.

Authors:  Julio Brito; Patricia Siques; Silvia M Arribas; Angel L López de Pablo; M Carmen González; Nelson Naveas; Karem Arriaza; Karen Flores; Fabiola León-Velarde; Ruth Pulido; Stefany Ordenes; M Rosario López
Journal:  Biomed Res Int       Date:  2015-02-08       Impact factor: 3.411

5.  Downregulation of microRNA-637 Increases Risk of Hypoxia-Induced Pulmonary Hypertension by Modulating Expression of Cyclin Dependent Kinase 6 (CDK6) in Pulmonary Smooth Muscle Cells.

Authors:  Hai-Yan Sang; Ying-Li Jin; Wen-Qi Zhang; Li-Bo Chen
Journal:  Med Sci Monit       Date:  2016-10-29

6.  Pri-microRNA-124 rs531564 polymorphism minor allele increases the risk of pulmonary artery hypertension by abnormally enhancing proliferation of pulmonary artery smooth muscle cells.

Authors:  Quanzhong Li; Zongjie Qian; Linqing Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-05-04

Review 7.  Hypoxic Pulmonary Vasoconstriction in Humans: Tale or Myth.

Authors:  A Hussain; M S Suleiman; S J George; M Loubani; A Morice
Journal:  Open Cardiovasc Med J       Date:  2017-01-24

8.  Apoptosis signal-regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension.

Authors:  Kathryn S Wilson; Hanna Buist; Kornelija Suveizdyte; John T Liles; Grant R Budas; Colin Hughes; Margaret R MacLean; Martin Johnson; Alistair C Church; Andrew J Peacock; David J Welsh
Journal:  Pulm Circ       Date:  2020-05-18       Impact factor: 3.017

9.  Hypoxia promotes progesterone synthesis during luteinization in bovine granulosa cells.

Authors:  Shin Yoshioka; Ryo Nishimura; Kiyoshi Okuda
Journal:  J Reprod Dev       Date:  2014-03-01       Impact factor: 2.214

Review 10.  Novel Therapeutic Targets for Hypoxia-Related Cardiovascular Diseases: The Role of HIF-1.

Authors:  Minxuan Liu; Gina Galli; Yilin Wang; Qiru Fan; Zhenzhong Wang; Xin Wang; Wei Xiao
Journal:  Front Physiol       Date:  2020-07-15       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.